Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Sophie, Agaugué"'
Autor:
Thủy Nguyễn, Sophie Agaugué, Caroline Lonez, Eytan Breman, Benjamin Violle, Jennifer Bolsee, Jerome Marijsse
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/6fe501dc38a34959988ebd2b5ff199ba
Autor:
Aude de Gassart, Daniel Olive, Clement Ghigo, Patrick Brune, Emmanuel Valentin, Sophie Agaugué, Paul Frohna
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/93ddfb717d944fab8784021068a04b22
Autor:
Ryan Swanson, Aude de Gassart, Patrick Brune, Sophie Agaugué, Paul Frohna, Loui Madakamutil, Maelle Mairesse, Carl Walkey
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/93e755551a854f069bc9dbac4fdeb00b
Autor:
Jennifer Sims, Patrick Brune, René Hoet, Emmanuel Valentin, LE Suong, Sophie Agaugué, Remy Castellano, Alem Truneh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/3ffb4527f9ad4159b479abf8c71c43ca
Autor:
Jennifer Sims, Patrick Brune, René Hoet, Emmanuel Valentin, LE Suong, Sophie Agaugué, Paul Frohna
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/f98ed9e718924a69b440bb106f4be7b2
Autor:
Eytan Breman, Benjamin Demoulin, Sophie Agaugué, Sebastien Mauën, Alexandre Michaux, Lorraine Springuel, Julien Houssa, Fanny Huberty, Céline Jacques-Hespel, Céline Marchand, Jérôme Marijsse, Thuy Nguyen, Nancy Ramelot, Benjamin Violle, Dorothée Daro, Peter De Waele, David E. Gilham, Valérie Steenwinckel
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
Chimeric Antigen Receptor (CAR) T cells expressing the fusion of the NKG2D protein with CD3ζ (NKG2D-CAR T Cells) acquire a specificity for stress-induced ligands expressed on hematological and solid cancers. However, these stress ligands are also tr
Externí odkaz:
https://doaj.org/article/3a89e9c594694720a2cb44b8f7218adf
Autor:
Alexandre, Michaux, Sébastien, Mauën, Eytan, Breman, Marie-Sophie, Dheur, Laure, Twyffels, Laura, Saerens, Céline, Jacques-Hespel, Emilie, Gauthy, Sophie, Agaugué, David E, Gilham, Panagiota A, Sotiropoulou
Publikováno v:
Journal of Immunotherapy. 45:150-161
Allogeneic chimeric antigen receptor (CAR) T holds the promise of taking this therapeutic approach to broader patient populations while avoiding the intensive manufacturing demands of autologous cell products. One limitation to delivering an allogene
Autor:
David A. Sallman, Jason Brayer, Elizabeth M. Sagatys, Caroline Lonez, Eytan Breman, Sophie Agaugué, Bikash Verma, David E. Gilham, Frédéric F. Lehmann, Marco L Davila
Publikováno v:
Haematologica, Vol 103, Iss 9 (2018)
Externí odkaz:
https://doaj.org/article/9b7b7be87bdb4d579a61dcfd61aa11be
Autor:
Paul Frohna, Clément Ghigo, Emmanuel Valentin, Patrick Brune, Sophie Agaugué, Aude De Gassart, Daniel Olive
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundICT01, a novel, anti-BTN3A immunotherapeutic mAb for activating g9d2T cells, is currently evaluated in a Phase 1/2a clinical trial in patients with advanced-stage, relapsed/refractory cancer (NCT04243499, EVICTION). ICT01 indirectly activat
Autor:
Paul Frohna, Ryan Swanson, Sophie Agaugué, Patrick Brune, Maelle Mairesse, Carl Walkey, Aude De Gassart, Loui Madakamutil
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Backgroundγ9δ2 T-cells are attractive mediators of cancer immunotherapy due to their strong cytolytic and pro-inflammatory activities and the positive correlation between tumor infiltration and good prognosis [1,2]. ICT01, a novel anti-BTN3A mAb ac